Skip to main content
Signal8

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

$QNTMPress releaseJun 2, 2026, 7:40 AM ETRead the release

Quantum BioPharma has entered into a six-month agreement with IR Agency LLC (operating through Stocks.news) for investor relations and marketing services. The company will pay a fee of US$250,000 for the engagement, which begins on June 8, 2026.

Key figures

Ir agreement fee
250000
Unbuzzd royalty cap
250000000
Unbuzzd ownership pct
19.84
Ir agreement duration months
6

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.